Logo
x

Search

Subscribe Now

BMS

BMS Reports the EMA’s Validation of Application for Opdivo Plus Yervoy to Treat Hepatocellular Carcinoma

BMS Reports the EMA’s Validation of Application for Opdivo Plus Yervoy to Treat Hepatocellular Carcinoma

  • July 19, 2024
BMS’ Krazati Receives the US FDA’s Accelerated Approval to Treat Locally Advanced or Metastatic Colorectal Cancer (mCRC)

BMS’ Krazati Receives the US FDA’s Accelerated Approval to Treat Locally Advanced or Metastatic Colorectal Cancer (mCRC)

  • June 25, 2024
BMS Reports the EMA’s Validation of the Application for Subcutaneous Opdivo

BMS Reports the EMA’s Validation of the Application for Subcutaneous Opdivo

  • June 21, 2024
BMS Reports the US FDA’s Accelerated Approval of Augtyro to Treat Locally Advanced or Metastatic Solid Tumors

BMS Reports the US FDA’s Accelerated Approval of Augtyro to Treat Locally Advanced or Metastatic Solid Tumors

  • June 14, 2024
BMS Features the P-III (CheckMate -9DW) Trial Data of Opdivo Plus Yervoy for Treating Advanced Hepatocellular Carcinoma at ASCO 2024

BMS Features the P-III (CheckMate -9DW) Trial Data of Opdivo Plus Yervoy for Treating Advanced Hepatocellular Carcinoma at ASCO 20...

  • June 5, 2024
BMS Highlights Data from three P-III Studies of Breyanzi to Treat Various B-Cell Malignancies at ASCO 2024

BMS Highlights Data from three P-III Studies of Breyanzi to Treat Various B-Cell Malignancies at ASCO 2024

  • June 4, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.